Canada· CA-DIN-02405024
PERJETA-HERCEPTIN
A pertuzumab und trastuzumab product containing pertuzumab + trastuzumab, registered in Canada by HOFFMANN-LA ROCHE LIMITED. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Pertuzumab und trastuzumab is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FY01 (pertuzumab und trastuzumab), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Pertuzumab und trastuzumab · ATC L01FY01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- PERTUZUMAB + TRASTUZUMAB
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Country
- Canada (CA)
- ATC code
- L01FY01
- ATC class
- Pertuzumab und Trastuzumab
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab und trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPHESGO 1200 MG/600 MG SOLUCION INYECTABLERoche Registration Gmbh
- FinlandPhesgoAbacus Medicine A/S
- CzechiaPHESGORoche Registration GmbH, Grenzach-Wyhlen
- FrancePHESGO 1200 mg/600 mg, solution injectableROCHE REGISTRATION (ALLEMAGNE)
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IrelandPhesgo 1200 mg/600 mg solution for injectionRoche Registration GmbH
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
- Norway · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9de3df5-0ced-4a8e-8b50-2e8b3900fee0 GET /v1/drugs/a9de3df5-0ced-4a8e-8b50-2e8b3900fee0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02405024",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01FY01",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "88985",
"strengths": [
"420 MG",
"440 MG"
],
"ahfs_class": null,
"substances": [
"PERTUZUMAB",
"TRASTUZUMAB"
],
"product_categorization": null
}See everything about pertuzumab und trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.